ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Vaccination"

  • 2022 American Transplant Congress

    Early Experience with Varicella Vaccination in Pediatric Heart Transplant Recipients

    A. Dipchand, M. Seifert-Hansen

    The Hospital of Sick Children, Toronto, ON, Canada

    *Purpose: International consensus guidelines to vaccinate children after transplant with varicella (VZV) vaccine exclude heart recipients due to insufficient evidence for safety, seroconversion rate, and…
  • 2022 American Transplant Congress

    Disparities in Low Respiratory Vaccination Among Solid Organ Transplant Recipients

    J. R. Felzer1, A. M. LeMahieu2, L. J. Finney Rutten2, Y. Juhn3, C. Wi3, R. M. Jacobson3, C. C. Kennedy1

    1Medicine, Mayo Clinic, Rochester, MN, 2Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 3Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN

    *Purpose: There are many potential infections post-transplant, with influenza as the most common vaccine-preventable infection the first 5 years post-transplant. Despite effective vaccines, uptake is…
  • 2022 American Transplant Congress

    Antibody Response and Cellular Phenotyping in Kidney Transplant Recipients Following Sars-CoV-2 Vaccination

    N. M. Ali1, J. Miles2, S. Mehta1, V. Tatapudi1, B. Lonze1, E. Weldon1, Z. Stewart1, C. DiMaggio1, J. Allen3, S. Gray-Gaillard3, S. Solis3, M. Tuen3, J. Leonard1, R. Montgomery1, R. Herati3

    1Transplant Institute, NYU Langone Health, New York, NY, 2CareDx, Brisbane, NY, 3NYU Langone Health, New York, NY

    *Purpose: Correlates of protection for SARS-CoV-2 vaccines are not well-established in kidney transplant recipients(KTRs). Studies have highlighted the importance of neutralizing antibodies(Abs), however data suggests…
  • 2022 American Transplant Congress

    Immunity Rates to Hepatitis B Among Solid Organ Transplant Recipients

    S. Kopf1, J. Walker2, K. Bruxvoort3, H. Budhwani3, A. Nellore4

    1Infectious Disease, University of Alabama at Birmingham Hospital, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3University of Alabama at Birmingham Hospital, Birmingham, AL, 4University of Alabama, Birmingham, AL

    *Purpose: Immunosuppression after transplantation decreases vaccine responsiveness. Thus, to be best protected from post-transplant communicable diseases, vaccination of organ transplant candidates in the pre-transplant period…
  • 2022 American Transplant Congress

    Adverse Renal Events After BNT162b2 Pfizer/BioNTech COVID-19 Vaccine in Kidney Transplant Recipients

    H. K. Sran1, E. Wong1, M. R. D'Costa2, A. Lim2, Q. Lim2, A. Vathsala1

    1National University of Singapore, Singapore, Singapore, 2National University Centre for Organ Transplantation, National University Hospital, Singapore, Singapore

    *Purpose: Adverse events of a novel mRNA vaccine are not well described in Kidney Transplant Recipients(KTR), especially the risk of immune activation or recurrent glomerulonephritis(GN),…
  • 2022 American Transplant Congress

    A Randomized, Controlled, Double-blind Trial Of Inulin To Boost Response To A Third Covid-19 Vaccine Dose In Kidney Transplant Recipients.

    J. Singer1, M. Tunbridge2, T. Salehi3, G. Perkins4, B. Grubnor-Bauk5, B. Sim3, T. Ying6, P. T. Coates3, S. J. Chadban1

    1Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia, 2Renal Medicine, Royal Adelaide Hospital, Adelaide, Australia, 3Royal Adelaide Hospital, Adelaide, Australia, 4School of Biological Sciences, University of Adelaide, Adelaide, Australia, 5Adelaide University, Adelaide, Australia, 6Royal Prince Alfred Hospital, Sydney, Australia

    *Purpose: Kidney transplant recipients (KTR) commonly exhibit inadequate responses to 2-dose COVID-19 vaccination schedules and remain at increased risk of severe COVID-19. Gut dysbiosis is…
  • 2022 American Transplant Congress

    Effect of Covid-19 Vaccination on Markers of Rejection in Heart Transplant Recipients

    Z. Pieters1, E. Bruno1, S. Kim1, S. De Sirkar1, M. Thomas1, S. B. Sharmin2, M. Liebo1, A. Heroux1, N. Clark1, G. Reid1, S. Uprichard2, M. Yu1

    1Medicine, Loyola University Medical Center, Maywood, IL, 2Loyola University Chicago, Chicago, IL

    *Purpose: Heart transplant recipients have worse survival with COVID-19 than the general population, highlighting the importance of vaccination in these patients. The impact of vaccination…
  • 2022 American Transplant Congress

    An Analysis of Serological Response and Infection Outcomes Following Oxford Astra-Zeneca (azd1222) and Pfizer-Biontech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Pancreas Transplant Patients

    A. Asderakis1, U. Khalid1, G. Koimtzis1, M. Ponsford2, L. Szabó1, L. Grant2, S. Jolles2, I. Humphreys3

    1Cardiff Transplant Unit, University Hospital of Wales, Cardiff, United Kingdom, 2Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom, 3Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom

    *Purpose: SARS-CoV-2 is associated with high mortality among transplant recipients. This study aims to compare the humoral responses between the Oxford-Astra-Zeneca(AZ) and BNT162b2(Pfizer-BioNTech) vaccines in…
  • 2022 American Transplant Congress

    Assessment of Humoral and Cellular Immune Responses to Sars Cov-2 Vaccination in Immunocompromised Renal Allograft Recipients

    B. Shin, R. Zhang, T. M. Gadsden, A. Petrosyan, A. Vo, N. Ammerman, S. Sethi, E. Huang, A. Peng, R. Najjar, J. Atienza, I. Kim, S. C. Jordan

    Cedars-Sinai Medical Center, Los Angeles, CA

    *Purpose: SARS CoV-2 vaccination elicits both robust humoral and T-cell immune responses in healthy individuals. However, a comprehensive assessment of immune responses to SARS-CoV-2 vaccination…
  • 2022 American Transplant Congress

    Mandatory Vaccine Requirements in Waitlisted Transplant Patients: A Transplant Center’s Perspective – A Call to Action

    M. Debroy1, K. Andreoni1, A. Beach2, K. Chavin1

    1University Hospitals Cleveland Medical Center/Case Western Reserve, Cleveland, OH, 2University Hospitals, Cleveland, OH

    *Purpose: The global pandemic caused by the SARS Cov-2 virus has caused unprecedented, previously unthinkable changes. COVID-19 infection in transplanted patients carries an ~ 30%…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 18
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences